BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 27531762)

  • 1. [Clinical Features and Prognosis of 227 cases of Acute Myeloid Leukemia with Cross-lineage Antigen Expression].
    Fang F; Zhu P; Zhang Y; Lu XZ; Dong YJ; Sun YH; Wang LH; Bu DF; Cen XN; Wang MJ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Aug; 24(4):990-7. PubMed ID: 27531762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Immunophenotype characteristics and prognosis of acute leukemia patients with cross expressing lymphoid and myeloid lineage associated antigens].
    Jiang NG; Chen XM; Zhu HL; Zhong L; Zeng TT; Jia YQ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Dec; 18(6):1405-9. PubMed ID: 21176339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Immunophenotyping of 106 adult patients with acute leukemia by flow cytometry].
    Xu B; Hu C; Miao XD; Wu YH; Yi ZS; Yang Y; Meng FY; Feng R; Liu QF; Liu XL; Zheng WY
    Di Yi Jun Yi Da Xue Xue Bao; 2003 Oct; 23(10):1043-6. PubMed ID: 14559689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Analysis of immunophenotypes and expressions of non-myeloid antigens in acute myeloid leukemia].
    Wang W; Xu Y
    Nan Fang Yi Ke Da Xue Xue Bao; 2020 Nov; 40(11):1639-1644. PubMed ID: 33243747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aberrant co-expression of CD19 and CD56 as surrogate markers of acute myeloid leukemias with t(8;21) in Taiwan.
    Chen SW; Li CF; Chuang SS; Tzeng CC; Hsieh YC; Lee PS; Chen CH; Huang WT; Hwang WS; Tsao CJ
    Int J Lab Hematol; 2008 Apr; 30(2):133-8. PubMed ID: 18333845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic relevance of immunophenotyping in 379 patients with acute myeloid leukemia.
    Chang H; Salma F; Yi QL; Patterson B; Brien B; Minden MD
    Leuk Res; 2004 Jan; 28(1):43-8. PubMed ID: 14630079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Immunologic characteristics and prognosis of acute myeloid leukemia M1].
    Zhao F; Chen Y
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Aug; 15(4):687-91. PubMed ID: 17708783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Analysis of Heterogeneous Biological Characteristics and Prognosis-Related Factors in AL Patients with Mistranslation-Expressed Lymphoid and Myeloid-Related Antigen].
    Ma J; He GM; Liu H; Gao XY; Zhu WJ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2018 Oct; 26(5):1263-1268. PubMed ID: 30295236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Analysis of immunophenotype and leukemia associated immunophenotype in 610 patients with acute myeloid leukemia].
    Liu YR; Wang YZ; Chen SS; Chang Y; Fu JY; Li LD; Wang H; Yu H; Jiang B; Huang XJ
    Zhonghua Xue Ye Xue Za Zhi; 2007 Nov; 28(11):731-6. PubMed ID: 18457262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Immunophenotyping characteristics of AML and their correlation with the curative effects].
    Yang LL; Liu X; Li Q; Zhu XY; Wang XB; Zhu WB
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Feb; 22(1):1-5. PubMed ID: 24598640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Expression of CD19 and CD56 in AML Patients with RUNX1-RUNX1T1 Mutation and Its Clinical Significance].
    Hu ZL; Zhang F; Huang BJ; Pan SJ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2018 Jun; 26(3):727-732. PubMed ID: 29950211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The clinical characteristics of CD7+ CD56+ acute myeloid leukemias other than M0.
    Suzuki R; Ohtake S; Takeuchi J; Nagai M; Kodera Y; Hamaguchi M; Miyawaki S; Karasuno T; Shimodaira S; Ohno R; Nakamura S; Naoe T
    Int J Hematol; 2010 Mar; 91(2):303-9. PubMed ID: 20111912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Correlation of immunophenotype to cytogenetics and clinical features of adult acute myeloid leukemia].
    Wang XB; Zheng JE; Gu JX; Yao JX; Yang J; Liu J; Li XQ; He YL; Yu JM; Wei J; Liu ZP; Huang SA
    Ai Zheng; 2005 Jun; 24(6):667-71. PubMed ID: 15946475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The immunophenotypic analysis of CD7+ and (or) CD56+ acute myeloid leukemic stem cells and its applications in minimal residual disease detection].
    Cao H; Wang YZ; Wu HH; Chang Y; Hao L; Chen SS; Huang XJ; Lu DP; Liu YR
    Zhonghua Xue Ye Xue Za Zhi; 2008 Jan; 29(1):23-8. PubMed ID: 18512311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of CD7+CD56+ phenotype and chromosome 5 abnormalities for acute myeloid leukemia M0.
    Suzuki R; Murata M; Kami M; Ohtake S; Asou N; Kodera Y; Tomonaga M; Masaki Y; Kusumoto S; Takeuchi J; Matsuda S; Hirai H; Yorimitsu mS; Hamajima N; Seto M; Shimoyama M; Ohno R; Morishima Y; Nakamura S
    Int J Hematol; 2003 Jun; 77(5):482-9. PubMed ID: 12841387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD56 expression is an independent prognostic factor for relapse in acute myeloid leukemia with t(8;21).
    Iriyama N; Hatta Y; Takeuchi J; Ogawa Y; Ohtake S; Sakura T; Mitani K; Ishida F; Takahashi M; Maeda T; Izumi T; Sakamaki H; Miyawaki S; Honda S; Miyazaki Y; Taki T; Taniwaki M; Naoe T
    Leuk Res; 2013 Sep; 37(9):1021-6. PubMed ID: 23810283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Immunophenotypic Analysis of Patients with CD56⁺ Acute Myeloid Leukemia].
    Guo R; Shen AL; Wang Y; Liu L; Zhang JF; Wang R; Li JY; Wu YJ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Oct; 23(5):1231-4. PubMed ID: 26524014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD56 and PGP expression in acute myeloid leukemia: impact on clinical outcome.
    Raspadori D; Damiani D; Michieli M; Stocchi R; Gentili S; Gozzetti A; Masolini P; Michelutti A; Geromin A; Fanin R; Lauria F
    Haematologica; 2002 Nov; 87(11):1135-40. PubMed ID: 12414342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of CD56 antigen expression in acute myeloid leukemia.
    Di Bona E; Sartori R; Zambello R; Guercini N; Madeo D; Rodeghiero F
    Haematologica; 2002 Mar; 87(3):250-6. PubMed ID: 11869936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of the neural cell adhesion molecule CD56 is associated with short remission duration and survival in acute myeloid leukemia with t(8;21)(q22;q22).
    Baer MR; Stewart CC; Lawrence D; Arthur DC; Byrd JC; Davey FR; Schiffer CA; Bloomfield CD
    Blood; 1997 Aug; 90(4):1643-8. PubMed ID: 9269784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.